Found 7 matching trials
An Open-Label Study to Evaluate the Safety of NP101 in the Treatment of Acute Migraine Over Twelve Months PHASE3 This study will use an open-label design to evaluate the safety of NP101. A...
Show More Location
Multiple Locations
Learn More & Join Trial
An Open-Label Study to Evaluate the Safety of NP101 in the Treatment of Acute Migraine Over 12 Months PHASE3 The primary objective is to evaluate the safety of long-term treatment with...
Show More Location
Multiple Locations
Learn More & Join Trial
The Efficacy and Tolerability of NP101 Patch in the Treatment of Acute Migraine PHASE3 This study was a randomized, parallel group, double-blind, placebo controll...
Show More Location
Multiple Locations
Learn More & Join Trial
Compare PK and Bioavailability of 2 NP101 Patches With Oral Imitrex in Healthy Adults PHASE1 The purpose of this research is to:
1. Compare two study patches having mi...
Show More Location
Prism Research, LLC
Learn More & Join Trial
Phase I Open Label Single-Dose Study to Compare the Pharmacokinetics of NP101 Healthy Volunteers PHASE1 The primary objective is to compare the pharmacokinetics (PK) profiles amon...
Show More Learn More & Join Trial
Phase I Study to Compare NP101(Sumatriptan Iontophoretic Transdermal Patch) With Three Formulations of Imitrex® PHASE1 The primary objective is to compare the pharmacokinetics (PK) of NP101 with...
Show More Location
Orlando Clinical Research Center
Learn More & Join Trial
Phase I, Open Label, Single-Dose, Four Way Crossover Study to Compare the PK of NP101 With Oral Imitrex® (50mg) in Migraine Subjects During an Acute Migraine Attack and During a Non-Migraine Period PHASE1 To compare the pharmacokinetics of NP101 with a currently approved oral for...
Show More Learn More & Join Trial